Cargando…
Brain Activation by Peptide Pro-Leu-Gly-NH(2) (MIF-1)
MIF-1 (Pro-Leu-Gly-NH(2)) is a tripeptide for which the therapeutic potential in Parkinson's disease and depression has been indicated by many studies. However, the cellular mechanisms of action of MIF-1 are not yet clear. Here, we show the specific brain regions responsive to MIF-1 treatment b...
Autores principales: | Khan, Reas S., Yu, Chuanhui, Kastin, Abba J., He, Yi, Ehrensing, Rudolph H., Hsuchou, Hung, Stone, Kirsten Prufer, Pan, Weihong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915805/ https://www.ncbi.nlm.nih.gov/pubmed/20721355 http://dx.doi.org/10.1155/2010/537639 |
Ejemplares similares
-
Fibroblast growth factor 19 entry into brain
por: Hsuchou, Hung, et al.
Publicado: (2013) -
Leptin action on nonneuronal cells in the CNS: potential clinical applications
por: Pan, Weihong, et al.
Publicado: (2012) -
TNF Stimulates Nuclear Export and Secretion of IL-15 by Acting on CRM1 and ARF6
por: Ouyang, Suidong, et al.
Publicado: (2013) -
Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor
por: Bhagwanth, Swapna, et al.
Publicado: (2013) -
Leukocyte infiltration across the blood-spinal cord barrier is modulated by sleep fragmentation in mice with experimental autoimmune encephalomyelitis
por: He, Junyun, et al.
Publicado: (2014)